Psychology by BogdanovaThe Encyclopedia of Psychology for the Artificial Era

RESEARCH DOSSIER

Psychological Treatments for Trauma and PTSD

Abstract. This fundamental research monograph analyzes psychological treatments for posttraumatic stress disorder and persistent trauma-related difficulties through critical narrative synthesis of original randomized controlled trials, measurement studies, therapeutic theories, meta-analyses, and current professional guidelines. It reconstructs the historical development and mechanisms of prolonged exposure, cognitive processing therapy, cognitive therapy, eye movement desensitization and reprocessing, narrative exposure therapy, written exposure therapy, and related approaches. Special attention is given to young people, complex PTSD, dissociation, comorbidities, cultural and military contexts, risk, treatment delivery, and the interpretive limits of comparative evidence. The synthesis finds substantial evidence for multiple trauma-focused psychotherapy packages while demonstrating that comparative superiority, individual treatment matching, causal mechanisms, adverse events, and durable recovery require more precise research. It situates developments in measurement and automated clinical support within the Artificial Era without treating unvalidated artificial systems as clinically equivalent to professionally delivered psychotherapy. This work is a critical narrative scientific synthesis, not an original clinical trial, preregistered systematic review, or meta-analysis.

Keywords: psychological treatments for PTSD; posttraumatic stress disorder; trauma-focused cognitive behavioral therapy; prolonged exposure; cognitive processing therapy; eye movement desensitization and reprocessing; complex PTSD; childhood trauma; written exposure therapy; narrative exposure therapy; randomized controlled trials; psychotherapy mechanisms; treatment effectiveness; clinical safety; Artificial Era.

Introduction and Research Object

Psychological treatment of trauma-related mental disorder is a field of clinical science concerned with altering the persistence, intensity, interpretation, and functional consequences of traumatic stress reactions. Its central question is how structured psychological interventions enable people whose responses to a potentially traumatic event remain distressing or disabling to regain the capacity for flexible memory, emotion, judgment, relationships, and purposeful action. The subject encompasses treatment of posttraumatic stress disorder (PTSD) in adults and young people, the investigation of trauma-focused therapeutic mechanisms, the evaluation of comparative outcomes, and the difficult task of determining how evidence established in selected clinical samples translates to routine care.

Exposure to a potentially traumatic event is an exposure criterion, rather than a diagnosis. The World Health Organization. (2024 (n.d.) emphasizes that many exposed people recover naturally, whereas a smaller proportion develop PTSD. Interventions aimed at preventing chronic disorder immediately after an event therefore answer a different question from psychotherapies for established PTSD. Both questions require attention, but their outcome denominators, risks, treatment timing, and evidentiary requirements differ.

This monograph adopts the critical narrative synthesis as its research method. It examines foundational theoretical formulations; original randomized controlled trials; measurement studies; systematic reviews and network meta-analyses; and the 2023 VA/DoD, 2025 APA, NICE, and WHO guidance in force or publicly available by November 3, 2026. It does not report a preregistered database search, a systematic review conducted de novo, or original patient data. The research questions concern which interventions improve PTSD outcomes, the explanatory mechanisms proposed for their effects, what head-to-head comparisons establish, how developmental and complex presentations alter the clinical problem, and what remains uncertain about sustained recovery and access.

The organizing distinction is between the clinical outcome established by a trial, the theoretical process that might produce that outcome, and the professional recommendation derived from multiple forms of evidence. A symptom decrease after treatment establishes an observed change within a defined study design. Random allocation against an appropriate comparator strengthens causal inference for the treatment package. It does not, by itself, isolate a single mechanism such as habituation, memory updating, cognitive restructuring, eye movements, or therapeutic alliance. That distinction governs the interpretation of every intervention discussed below.

PTSD, Trauma Exposure, and Diagnostic Boundaries

PTSD is characterized by clinically significant and enduring posttraumatic symptoms involving intrusive reexperiencing, avoidance of trauma-related cues, enduring negative changes in cognition or mood, and heightened arousal or reactivity in the DSM-5 framework. The ICD-11 formulation uses a narrower core of reexperiencing in the present, avoidance, and a persistent perception of current threat, with a separately defined complex PTSD condition encompassing disturbances in self-organization. Diagnostic traditions overlap substantially while classifying some presentations differently. Treatment comparisons must therefore record which system was used, how the traumatic event was identified, and which outcome instrument was applied.

A trauma-related memory may be intrusive without fulfilling all diagnostic criteria. Distress, shame, grief, sleep disturbance, social withdrawal, chronic pain, and impaired functioning may require assessment beyond a symptom checklist. Conversely, a PTSD screening score alone does not establish a clinical diagnosis. A well-defined research population includes the nature and recency of exposure, symptom duration, diagnostic status, severity, relevant comorbidity, and any safety conditions that modify the setting of treatment.

The U.S. Department of Veterans Affairs (n.d.) illustrates the operational difference. Its structured interview considers the index event, symptom frequency and intensity, distress, impairment, duration, and dissociative subtype. In trials, outcomes may be clinician-rated symptom severity, self-reported symptoms, loss of diagnostic status, response, remission, treatment discontinuation, or improvement in occupational and social functioning. These outcomes should not be treated as interchangeable endpoints.

The phrase psychological treatments for trauma and PTSD encompasses heterogeneous interventions and heterogeneous objectives. In established PTSD, trauma-focused psychotherapy aims to change the person's relationship to threat-related memory and meaning. In the immediate aftermath of trauma, proportionate support and surveillance often address natural recovery, safety, practical needs, and the identification of people with acute stress disorder or persistent symptoms. In complex clinical presentations, treatment may additionally target emotional regulation, interpersonal disturbances, dissociation, depression, substance use, and ongoing environmental danger. Scope must remain clinically and methodologically explicit.

Historical Development of Trauma Psychotherapy

The modern treatment literature emerged through converging but historically distinct traditions: clinical observations of traumatic memory and dissociation, behavior therapy's exposure procedures, cognitive accounts of maladaptive appraisal, and therapies that organize traumatic recollection into coherent autobiographical meaning. Clinical documentation of traumatic reactions long preceded contemporary diagnostic criteria, but the consolidation of PTSD as a recognized clinical category created shared samples, operational outcome measures, and a progressively testable therapeutic research program.

Foa (1986) formulated emotional processing theory as a model of fear structures and corrective information. Its practical significance lay in treating avoidance as a maintainer of pathological fear and repeated therapeutic confrontation as a condition under which new information could modify fear-related structures. This theory informed exposure-based intervention development; subsequent learning accounts have broadened the explanatory possibilities beyond within-session fear reduction.

Shapiro (1989) investigated a procedure incorporating recalled traumatic material and guided eye movements in a small sample. The study has historical significance for the development of eye movement desensitization and reprocessing (EMDR), yet its small early design should be distinguished from the later body of randomized comparisons. The question of whether bilateral stimulation supplies a specific causal ingredient remains distinct from whether a complete manualized EMDR treatment can reduce PTSD symptoms.

Resick (2002) directly compared cognitive processing therapy (CPT), prolonged exposure (PE), and a minimal-attention comparison among female rape survivors, strengthening the experimental foundations of both procedures. Ehlers (2000) offered a cognitive explanation of enduring current threat through problematic trauma appraisals and autobiographical memory processing. Ehlers (2005) subsequently described and evaluated a corresponding therapy program.

The ensuing research history includes large multisite trials, direct comparison of active treatments, youth-specific caregiver-involved protocols, brief written interventions, and trials under conditions of military service, displacement, or complex trauma. Clinical guidelines increasingly grade treatment-specific evidence rather than assuming that all therapies carrying the label trauma-focused CBT are equivalent. Historical development is therefore a succession of empirical refinements in protocol, sample, comparison condition, measurement, and follow-up.

Theoretical Mechanisms of Therapeutic Change

Exposure models propose that approaching trauma-linked memories, images, bodily cues, and previously avoided situations in a supported therapeutic setting changes the individual's expectancies and response patterns. Emotional processing theory, inhibitory learning, and retrieval-based interpretations offer related but separable explanatory accounts. The observation that avoidance can maintain fear is compatible with several different neural and cognitive mechanisms; determining which mechanism mediates durable improvement requires repeated, properly timed measurement and experimental manipulation rather than post hoc narrative alone.

The cognitive formulation of Ehlers (2000) places the continuing experience of current threat at the center of persistent PTSD. Negative appraisals about responsibility, permanent damage, interpersonal safety, and personal competence interact with trauma-memory qualities and strategies such as suppression, monitoring, and avoidance. Cognitive treatment aims to change the meanings sustaining current threat while improving contextual access to the traumatic memory.

CPT gives particular attention to trauma-related beliefs and the interpretation of the event and its aftermath. Cognitions about safety, trust, power, esteem, and intimacy may organize persistent shame or guilt. Therapeutic change may occur through examination of rigid assumptions, new contextual evidence, and a reduction in avoidance. A claim that changes in beliefs mediate improvement is stronger than a claim that beliefs change during improvement; convincing mediation requires longitudinal design, temporal ordering, attention to measurement error, and control of alternative paths.

EMDR integrates access to distressing traumatic memories with structured dual-attention stimulation and therapeutic reprocessing. Lee (2013) studied the contribution of eye movements to emotional memory processing in a meta-analysis, providing evidence relevant to a component hypothesis. Such component findings do not alone establish a unique neurobiological pathway explaining the outcomes of complete EMDR treatment, nor do mechanistic disagreements negate the evidence for treatment effects observed in comparative trials.

Across methods, relationship quality, credible rationale, repeated engagement, behavioral activation, cognitive flexibility, and changes in environmental safety may jointly influence outcome. The most scientifically useful architecture therefore models therapy as a multicomponent intervention. A productive research agenda combines dismantling designs, repeated process measures, cross-lagged temporal tests, experimental manipulation of hypothesized ingredients, and longitudinal functional outcomes rather than assigning all therapeutic improvement to a preferred single theory.

Diagnosis and Measurement in Treatment Research

The quality of psychotherapy evidence depends partly on the quality of the instrument used to decide who entered a trial and whether they improved. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) provides a structured interview administered by trained clinicians, whereas the PTSD Checklist for DSM-5 (PCL-5) records self-reported symptom severity. These instruments contribute different forms of evidence: diagnostic assessment with standardized probing and scalable repeated symptom monitoring.

Weathers (2018) described the development and initial psychometric evaluation of CAPS-5 in military veteran samples. Bovin (2016) examined PCL-5 properties in veteran care samples. Initial validation in these populations supports use in related settings, while translation, age, trauma type, cultural experience, and treatment context remain important when interpreting a given threshold or change score. Measurement invariance cannot be assumed from the availability of a translated questionnaire.

Trials frequently use change from pretreatment to a specified endpoint as the primary estimand. An intervention may produce substantial mean symptom reduction while leaving some participants symptomatic. Loss of PTSD diagnosis requires a prespecified diagnostic rule; remission requires another threshold; functional restoration requires evidence about life beyond symptom counts. These distinctions become particularly consequential when active treatments produce similar average reductions but differ in completion, acceptability, speed of recovery, or domains of functioning.

Blinded outcome assessors can reduce detection bias, even though the nature of psychotherapy commonly prevents masking participants and therapists to treatment assignment. Self-report and observer-rated outcomes may diverge through expectancy, therapeutic allegiance, demand characteristics, or changing interpretation of questions. Treatment fidelity measurements assess whether the intended protocol was delivered; therapist competence and supervision influence whether outcome evidence can reasonably be generalized to routine implementation.

Research evaluating clinically important change should report its calculation, measurement error, baseline severity, follow-up interval, and whether the analysis includes all randomized participants. A completer analysis disproportionately represents people who could remain in treatment. Intent-to-treat estimation addresses a different policy question, concerning what happens when a treatment strategy is offered to an initially eligible population. The contrast is central to interpretation of both efficacy and service effectiveness.

Research Designs and the Hierarchy of Evidence

The strongest causal test of a psychotherapy package generally randomizes eligible patients to well-defined treatments and obtains comparable outcome measurements across groups. The comparator changes the question being answered. A waitlist comparison estimates benefit over delayed access under the trial's conditions; present-centered or supportive psychotherapy assesses incremental effects against an active credible alternative; direct comparison of PE and CPT estimates their relative performance in a particular sample and delivery context. Combining such contrasts without qualification creates misleading apparent rankings.

Pragmatic trials add a different contribution by examining outcomes in ordinary services, where therapist caseload, patient complexity, logistical barriers, and treatment choice may differ from specialist efficacy studies. Their ecological validity increases as protocol and selection resemble routine practice, but loss of experimental control can complicate attribution. Implementation studies explain whether a treatment can be delivered reliably, at scale, with acceptable access and patient experience; they cannot replace randomized evidence for efficacy.

Network meta-analysis combines direct and indirect randomized comparisons under transitivity and consistency assumptions. Its ranking statistics do not convert sparse comparisons into secure evidence of treatment superiority. The 2023 synthesis of 157 trials involving 11,565 participants found evidence of benefit for multiple psychological interventions compared with controls, while also highlighting small relative differences among major classes and stronger longer-term performance for trauma-focused CBT than non-trauma-focused approaches. Its conclusions depend on intervention taxonomy, comparison network, trial characteristics, and the definition of acceptability.

Guideline committees must additionally judge certainty, benefits, burden, preferences, feasibility, equity, and the relevance of specific trials to their populations. U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder. https://www.healthquality.va.gov/guidelines/mh/ptsd/ (2023) and American Psychological Association. (2025). Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. American Psychological Association. https://www.apa.org/ptsd-guideline (2025) follow explicit evidence-review procedures while serving somewhat different professional and health-system contexts. Recommendations should therefore be read with their strength and population stated, rather than abstracted into a universal league table.

This monograph's evidence synthesis treats randomized trials and independent meta-analyses as the primary basis of efficacy claims, process studies as evidence about possible mechanisms, and clinical guidance as evaluated professional translation. The resulting narrative is comprehensive across principal mechanisms and treatment families, but has no claim to the reproducible search yield or pooled estimates of an original systematic review.

Psychological Treatment Selection and Patient-Centered Care

Treatment selection joins the evidence about effectiveness with the circumstances of the person seeking help. PTSD treatment research establishes a group-level probability distribution of outcomes, not the clinical trajectory of any particular individual. Relevant assessment dimensions include symptom pattern and duration, dissociation, depression, suicidality, substance use, functional impairment, current trauma exposure, physical illness, preferences about memory-focused work, therapist competence, and access to follow-up.

The Schnurr (2024) recommends three specific trauma-focused psychotherapies—PE, CPT, and EMDR—as principal evidence-supported options, with additional suggestions for several alternatives. National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018) recommends individual trauma-focused CBT for adults with clinically important symptoms or a PTSD diagnosis more than one month after trauma, and describes protocol-based delivery with supervision. These sources establish strong first-line treatment categories while recognizing practical and population-specific considerations.

A shared decision addresses more than whether a patient can tolerate a procedure. It concerns the anticipated work of therapy, expected number and spacing of appointments, memory-focused techniques, privacy, cultural meaning, clinician availability, costs of travel or online participation, the prospects of recovery, and the possibility of incomplete response. Engagement tends to improve when goals and procedures are comprehensible and revisited as treatment develops. The appropriate design also accounts for the difference between collaboratively selected pacing and indefinite avoidance of an evidence-based procedure.

Safety assessment runs alongside treatment selection. Acute risk, unstable housing, coercion, ongoing violence, severe dissociative episodes, and inaccessible follow-up may require adjustments in care coordination and clinical monitoring. Such factors should be observed rather than used automatically as categorical exclusions from trauma-focused treatment; indiscriminate exclusion would narrow access and distort the populations represented in future research. The clinical choice remains individual and requires appropriately qualified professionals.

The research outcome of interest is a documented, sustained improvement in symptoms and everyday function that the person regards as meaningful. A patient who improves on standardized symptoms but remains unable to work, sleep, connect with others, or avoid ongoing danger has an outcome that deserves further scientific and clinical attention. Patient-centered treatment research should therefore measure priorities rather than treating symptom severity as the only valid success metric.

Evidence-Based Guidelines in Comparative Perspective

Three major guideline systems illustrate how the same underlying clinical literature becomes a professional recommendation. The U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder. https://www.healthquality.va.gov/guidelines/mh/ptsd/ (2023) strongly favors individually delivered, manualized PE, CPT, and EMDR for PTSD within its adult clinical population. National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018) includes multiple forms of trauma-focused CBT, with a separately specified place for EMDR and supported computerized CBT under defined circumstances. The World Health Organization. (2024 (n.d.) identifies trauma-focused CBT and EMDR as the treatment approaches with the strongest evidence in its international public-health overview.

The American Psychological Association. (2025). Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. American Psychological Association. https://www.apa.org/ptsd-guideline (2025) is particularly important for an American scientific audience because it revises the earlier APA policy in the light of updated evidence, weighing clinical benefit, potential harm, patient values, and applicability. Readers comparing older professional summaries should verify whether they cite the 2017 document or the 2025 revision. Eberle (2026) examined ten international guidelines and documented meaningful variation in how specific treatments are ranked, a finding about guideline convergence and divergence rather than a new randomized estimate of comparative efficacy.

The differences among recommendations arise in part from the inclusion and exclusion of studies, classification of modalities, certainty methods, treatment populations, and the normative value assigned to outcomes and patient preferences. A recommendation may be strong because multiple reliable comparisons show benefit and tolerable burdens; another may be conditional because evidence is sparse, indirect, or methodologically inconsistent. Silence about a particular intervention should not automatically be interpreted as proof that it is ineffective.

Where guideline recommendations and new research appear to differ, the scientist must compare the evidence search dates. A guideline formally published in one year may draw on an evidence cutoff several years earlier. Equally, a recent meta-analysis may add statistical precision without improving validity if the included trials share bias, inconsistent definitions, or poorly represented groups. This monograph treats the professional guidance as an essential clinical anchor and evaluates newer reports without mechanically replacing a clinical recommendation with the newest pooled estimate.

The practical conclusion of this comparative overview is a hierarchy of research questions rather than an absolute ordering of therapies. There is a robust basis for offering well-delivered trauma-focused psychotherapy to adults with PTSD; there is ongoing work to distinguish treatment packages, identify patients who benefit from different approaches, measure harms, improve access, and establish durable restoration of functioning.

Prolonged Exposure Therapy

Prolonged exposure (PE) is an individually delivered, manualized treatment that addresses trauma-related avoidance through systematic therapeutic engagement with trauma memories and avoided but reasonably safe situations. The central procedures usually distinguish imaginal exposure to the memory from in vivo exposure to reminders and activities whose avoidance restricts everyday life. Treatment also includes a coherent rationale, monitoring of reactions, and the review of new learning. The clinical aim is a progressive change in how traumatic reminders are interpreted and approached, rather than the elimination of all normal emotional reactions to loss or danger.

In an influential randomized trial, Foa (2005) assigned 171 female assault survivors with chronic PTSD to PE, PE with added cognitive restructuring, or a waitlist control. Both active treatments reduced symptoms relative to waiting, and the study examined whether explicit cognitive restructuring increased effectiveness. The result supported PE as an effective intervention and demonstrated the importance of dismantling designs: improving cognition does not necessarily require a separately named cognitive module to produce clinical change.

Schnurr and colleagues (2007) conducted a multisite randomized comparison of PE and present-centered therapy among female veterans and active-duty personnel. The study reported greater PTSD symptom reduction and greater loss of diagnostic status in the PE group, although the absolute outcomes also showed many patients with remaining symptoms. These findings strengthened the case for military-system delivery while highlighting that statistically significant superiority does not guarantee remission for most participants.

A much larger trial by Schnurr (2022) randomized 916 U.S. veterans to PE or CPT. Both treatments produced substantial improvement; PE's advantage on the prespecified primary comparison was statistically detectable but small and judged below clinical significance. This is more clinically informative than either asserting that the therapies are interchangeable in every setting or declaring a superior treatment based on a p-value alone.

Exposure-based treatment is implemented by clinicians trained to distinguish feared but safe reminders from genuinely unsafe present circumstances. Regular review of symptoms, dissociation, readiness, and functional outcomes permits adjustment without equating momentary distress during treatment with harm or treatment failure. The leading unresolved issues concern the best mechanisms of change, how to predict individual response, why some patients discontinue, and how to translate protocol fidelity into ordinary resource-limited services.

Cognitive Processing Therapy

Cognitive processing therapy (CPT) is a structured intervention developed to address trauma-related beliefs that keep the experience psychologically active as present danger, moral condemnation, or permanent loss of agency. It engages the interpretations people make about the causes and consequences of trauma, including responsibility, safety, trust, control, esteem, and intimacy. Therapeutic work commonly examines rigid or overgeneralized conclusions and tests more contextualized alternatives without prescribing a required emotional narrative.

The pivotal Resick (2002) trial randomized 171 women who had experienced rape to CPT, PE, or a minimal-attention comparison, with 121 completing treatment. Both active interventions showed efficacy on PTSD and depressive outcomes. CPT showed an advantage on selected guilt-related measures, an observation consistent with its explicit attention to trauma-related attributions but insufficient on its own to prove a unique mediating pathway.

CPT's later development included formats that do not require a written account of the index trauma. This matters for the conceptual classification of therapies. A cognitive intervention can be explicitly trauma-focused while differing in the depth, duration, and form of direct exposure. A person's preference for or against a particular kind of trauma narrative therefore does not map neatly onto a choice between treating and avoiding the trauma.

The large Schnurr (2022) with PE supports the clinical standing of both treatments. The stronger evidence for average improvement should be kept separate from a claim that CPT has a unique advantage for every patient struggling with guilt, shame, or self-blame. Within-group cognitive change, therapist statements, and qualitative testimony can suggest hypotheses about which component matters, but carefully specified mediation and moderation analyses are required to test them.

Treatment fidelity requires trained clinicians to identify relevant beliefs while avoiding simplistic correction of culturally embedded or realistic appraisals. A person exposed to continuing discrimination, danger, or injustice may accurately assess aspects of the environment as unsafe. Therapeutic work is therefore directed to inflexible interpretations that persist beyond evidence and impair action, together with restoration of functioning and practical safety. The scientific question is how cognitive flexibility and trauma processing are integrated with the person's real social context.

Cognitive Therapy for PTSD

Cognitive therapy for PTSD, associated with Ehlers and colleagues, derives directly from the proposal that a persistent sense of current threat emerges from negative appraisals and characteristics of trauma memory. The Ehlers (2000) emphasizes poorly contextualized autobiographical recollection, associative retrieval, sensory priming, and behavioral strategies that prevent updating of traumatic meanings. This formulation predicts that targeting appraisals, memory hotspots, and maladaptive coping strategies should alter the experience of current danger.

The treatment described by Ehlers (2005) combines individualized case formulation, identification of trauma-related meanings, memory updating, and behavioral experiments. Its development work included an early case series and a small randomized comparison with a waiting condition. These studies demonstrate a coherent progression from theoretical model to operational intervention, though their small early samples demand interpretation alongside later independent evaluations and guideline review.

The model's particular scientific value lies in specifying candidate pathways from memory encoding and retrieval to ongoing symptom production. A reminder experienced as an immediate recurrence rather than a past event can cause acute physiological and cognitive reactions. When therapy links a distressing memory fragment to temporal, causal, and contextual information, the individual may begin to appraise the reminder as evidence of the past rather than proof of renewed danger.

The mechanisms are plausible and experimentally approachable, but an accurate theory of PTSD persistence and proof that a specified process mediates the effect of a manualized intervention are separate achievements. Researchers must examine whether changes in appraisals precede changes in symptoms, whether the measurements capture a distinct construct, and whether competing explanations such as alliance, engagement, or reduction in avoidance account for the same data.

The approach is relevant to patients whose most persistent difficulties concern traumatic guilt, shame, mental defeat, intrusive images, or extensive safety behaviors. Its placement in guidance such as National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018) reflects established clinical use, while head-to-head and mechanism research continue to refine the circumstances under which a focused cognitive strategy may offer distinctive practical value.

Eye Movement Desensitization and Reprocessing

Eye movement desensitization and reprocessing (EMDR) is a structured psychotherapy in which traumatic memories and associated beliefs, emotions, and bodily sensations are engaged while the patient follows a sequence of dual-attention stimulation. The protocol integrates preparation, identification of relevant targets, memory-focused processing, and later reassessment. Its distinctive procedural component is bilateral or otherwise alternating stimulation, commonly through guided eye movements.

The early Shapiro (1989) study served as a historical starting point for an intervention subsequently evaluated in substantially larger trials and reviews. Contemporary efficacy assessment concerns the complete EMDR protocol, not the assumptions of the original small demonstration. In the U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder. https://www.healthquality.va.gov/guidelines/mh/ptsd/ (2023), EMDR is one of three therapies specifically recommended for adult PTSD alongside CPT and PE. The World Health Organization. (2024 (n.d.) likewise identifies EMDR among the most evidence-supported psychological approaches.

Two distinct scientific questions must be maintained. First, does a full course of EMDR outperform waitlist, usual care, or an active alternative for PTSD outcomes? Second, what additional effect is attributable to eye movements after holding the rest of therapeutic processing approximately constant? The synthesis of Lee (2013) directly addressed memory-processing contributions of eye movements. The findings inform mechanistic hypotheses involving dual-task load and memory vividness, but heterogeneous experiments do not uniquely establish the biological architecture of all clinical effects.

Studies of memory vividness and laboratory distress are valuable intermediate outcomes, though reductions during a session differ from sustained clinical remission measured months after treatment. Definitive attribution of a mechanism requires component randomization in clinical populations, control of therapist and expectancy effects, and temporal measurement of proposed mediators and PTSD outcomes. Interventions should be compared on clinically meaningful endpoints even while mechanistic controversies continue.

The manualized approach requires practitioner competence, appropriate clinical assessment, and collaborative monitoring of dissociation and tolerability. A scientifically faithful discussion of EMDR recognizes a supported therapeutic intervention whose distinctive causal ingredients remain an active research question, rather than requiring either complete mechanistic endorsement or rejection.

Narrative Exposure Therapy and the Organization of Traumatic Memory

Narrative exposure therapy (NET) organizes traumatic events within a chronological life narrative, with particular relevance to repeated and multiple traumas encountered during war, persecution, forced displacement, or extreme interpersonal violence. The therapeutic premise is that a fragmented or decontextualized set of traumatic memories can be integrated with temporal and autobiographical context through sustained, supported narration. NET's distinctive feature is the construction of a broad life history rather than work exclusively on one index event.

In a study conducted in an African refugee settlement, Neuner (2004) compared NET, supportive counseling, and psychoeducation. The trial is important because participants faced conditions substantially different from specialist clinics in stable high-income settings. It widened the empirical question from whether trauma therapy works under ideal conditions to how manualized therapy can be studied where traumatic exposure, displacement, and limited resources coexist.

NET has been included among trauma-focused CBT approaches recommended in the National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018). Evidence should nevertheless be analyzed with attention to trial size, ongoing threats, cultural translation, mode of delivery, and the level of specialist support. A treatment developed in one crisis setting is not automatically valid for all refugee, migrant, or conflict-affected populations. Effectiveness may depend on security, continuity of care, trust, and whether the person's fundamental needs are addressed.

Narrative coherence has both descriptive and mechanistic interpretations. A more coherent autobiographical account after therapy might correlate with improvement, form one pathway of improvement, or partly reflect broader recovery. A process study that measures narrative organization before and after treatment cannot distinguish these alternatives without stronger design. Furthermore, culturally appropriate autobiographical expression varies; a western-language measure of narrative structure should not be used uncritically as a universal index of psychological recovery.

The most important translational lesson is that trauma-focused therapies must be evaluated in contexts where social and political conditions shape treatment. Therapeutic processing can have a role alongside safe housing, protection from violence, legal support, and community care. The intervention targets psychological consequences while the environment remains a scientifically meaningful determinant of ongoing stress.

Written Exposure Therapy and Brief Protocols

Written exposure therapy (WET) is a brief, structured treatment centered on repeated, therapist-supported written confrontation with traumatic memory and its meanings. Its research program asks whether a shorter intervention can produce clinically relevant benefit with less session burden, fewer opportunities for discontinuation, and feasible delivery in busy health systems. A reduction in treatment sessions is meaningful only when compared with appropriate clinical outcomes, acceptability, and longer-term durability.

In Sloan (2018), a randomized noninferiority study compared a brief exposure-based approach with CPT. Noninferiority designs are especially sensitive to the predefined clinical margin, adherence, missing data, analysis population, and whether the active comparator performed as expected. A result meeting the margin supports a specific conclusion under those trial conditions and cannot be turned into unrestricted equivalence for every clinical subgroup.

A subsequent randomized study among active-duty military personnel by Sloan (2022) compared five-session WET with CPT and reported evidence supporting noninferiority with lower discontinuation in the WET group. Sloan (2023) also compared WET with PE in a randomized trial. Together, these studies directly address service efficiency while reinforcing the importance of maintaining protocol-specific claims.

Time-limited care alters both clinical opportunities and research interpretation. If the comparator requires more sessions, posttreatment endpoints may occur at different calendar times. Recovery trajectories can therefore be influenced by exposure to time, intervening events, and the opportunity to access additional services. Treatment completion rates likewise reflect appointment burden, not merely subjective tolerability of trauma processing. Analyses of treatment efficiency should combine symptom change, dropout, clinician time, patient time, and follow-up.

VA/DoD guidance recognizes WET as a suggested intervention rather than assigning it the same recommendation status as PE, CPT, and EMDR. This distinction illustrates how promising randomized comparisons and a developing literature can be clinically important while the total evidence base remains narrower for some populations and outcomes.

Present-Centered and Non–Trauma-Focused Psychotherapy

Present-centered therapy (PCT) addresses current difficulties, relationships, problem solving, and day-to-day functioning without making direct trauma-memory processing the central technique. It has been used extensively as an active comparator in PTSD trials because it can offer a credible, structured clinical relationship while testing whether the more explicitly trauma-focused component adds benefit. PCT also has intrinsic clinical interest for people who do not choose trauma-memory-centered treatment.

The importance of an active comparator becomes evident in Schnurr and colleagues (2007), where PE produced superior average outcomes to PCT but PCT participants also received a genuine psychological treatment. Such a design supports an incremental inference that a waitlist comparison cannot make. Simultaneously, it does not establish that every element missing from PCT is responsible for the entire outcome difference.

The 2023 network meta-analysis of 157 randomized trials found that several psychological intervention classes improved PTSD symptoms relative to controls, while trauma-focused CBT showed a modest longer-term advantage over non-trauma-focused approaches. This warrants a careful interpretation: an intervention may have real benefit yet be less well supported as a first-line option for the core syndrome. Less directly focused therapy can also address distress, adjustment, practical difficulties, and therapeutic engagement that matter to people living with PTSD.

An additional Schaug (2025) reached more conditional conclusions for certain subgroups, including PTSD with co-occurring depression. Its low-certainty evidence and active-comparator variation discourage the assumption that the same hierarchy necessarily holds in every clinical presentation.

The field's open question is whether a given patient's choice for PCT reflects informed preference, temporary readiness, access barriers, or a different therapeutic objective. That question is best tested with preference trials, stepped-care studies, treatment sequencing, and meaningful functional outcomes rather than by dismissing clinically credible comparators as placebo.

Acute Stress, Early Intervention, and Prevention

The first days and weeks following trauma involve a different natural history from established PTSD. Distress, disrupted sleep, alertness, and intrusive recollection can occur during an adaptive recovery process. An intervention offered universally to all exposed people will therefore include many individuals who would recover without formal treatment, whereas indicated early treatment recruits people with acute stress disorder or clinically significant persistent symptoms.

The randomized investigation by Bryant (2008) evaluated treatments for acute stress disorder after trauma, comparing exposure-based and cognitive approaches with a waiting condition. Its contribution was to examine whether an indicated early intervention can alter the later risk and course of clinically important symptoms, rather than assuming that every survivor needs immediate intensive trauma processing.

By contrast, the Rose (2002) did not support compulsory single-session psychological debriefing as a means of preventing PTSD after traumatic incidents. This finding matters because the social appeal of an immediately structured emotional recounting is not a substitute for a demonstrated preventive benefit. Models of early assistance should distinguish humane support, practical coordination, optional follow-up, and targeted psychotherapy from compulsory postevent recounting.

The National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018) provides differentiated recommendations for acute stress disorder and clinically important symptoms within one month of exposure, and for PTSD or persistent symptoms after that period. Such recommendations depend on clinical assessment and timing. A person's need for urgent safety, medical care, shelter, information, or connection to community resources does not imply that they should immediately receive formal exposure therapy.

Research in early care should report the exposure-to-intervention interval, baseline risk, spontaneous improvement in controls, later diagnosis, disability, participant burden, and adverse effects. The relevant estimand may be prevention of new PTSD, reduction of acute symptoms, or restoration of practical functioning, each demanding a different design. A scientifically sound preventive service identifies those likely to benefit while avoiding interventions whose burden is borne by all survivors without equivalent evidence of benefit.

Children, Adolescents, and Caregiver-Involved Treatment

Psychological treatment of posttraumatic stress in children and adolescents requires a developmental model. Children's verbal autobiographical memory, cognitive appraisal, emotion regulation, dependence on caregivers, school functioning, and vulnerability to continued maltreatment differ from adult treatment conditions. Caregivers may contribute safety and reinforcement of therapeutic learning, yet their role must be assessed in relation to the actual source of trauma and the child's best interests.

Trauma-focused cognitive behavioral therapy for children (TF-CBT) combines developmentally adapted work on trauma memories with emotional regulation, cognitive coping, gradual exposure, and appropriately structured caregiver involvement. In a multisite randomized trial, Cohen (2004) assigned 229 children aged eight to fourteen years and their primary caregivers to TF-CBT or child-centered therapy for sexual abuse-related symptoms. The trial contributed randomized evidence for a treatment organized around the child's development and family context, and it evaluated symptoms beyond PTSD alone.

Cohen (2011) subsequently tested community-delivered TF-CBT for children exposed to intimate partner violence, an important extension of the research from more specialized settings toward local service delivery. Youth treatment effectiveness depends not only on clinical content but also on safeguarding, the safety and availability of an appropriate caregiver, developmental readiness, and whether the child's environment remains threatening.

World Health Organization. (2023). Post-traumatic stress disorder (PTSD): Psychological interventions (2023) supports psychological interventions including individual and group trauma-focused CBT and EMDR, with a strong recommendation and moderate certainty. National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018) differentiates age, time since trauma, and individual versus group delivery. These distinctions matter because extrapolating adult study results directly to young children can conceal major differences in symptom expression, consent, caregiving, and clinical protection.

Outcomes in developmental trials should include age-appropriate symptom instruments, caregiver reports, child-reported distress, functioning at school and home, family context, attendance, and long-term protection from recurrent harm. Agreement between child and caregiver reports cannot be assumed. A caregiver may observe behavior accurately while misunderstanding internal distress, or may have conflicting incentives about disclosure. Longitudinal research should examine whether symptom improvements persist through developmental transitions and changing family circumstances.

Complex PTSD and Disturbances in Self-Organization

Complex posttraumatic stress disorder (CPTSD) in ICD-11 comprises the core PTSD syndrome together with disturbances in self-organization, including problems in affect regulation, negative self-concept, and relationships. Its diagnostic definition is distinct from the broader clinical expression of complex trauma histories, borderline personality disorder, dissociative disorders, and severe repeated adversity. Studies that recruit patients because of childhood maltreatment alone do not automatically study a sample diagnosed with ICD-11 CPTSD.

Karatzias (2019) reviewed psychological interventions in trials with participants likely to exhibit components of complex PTSD. The authors found beneficial effects from several trauma-focused approaches but noted limitations in evidence quality and the challenge of matching the historical trials to newer diagnostic definitions. The central issue is whether existing evidence applies to the complete CPTSD construct or to selected symptoms commonly accompanying it.

A developmental hypothesis proposes that patients with significant affect dysregulation or relational disturbance might benefit from an initial skills phase before direct trauma-memory work. Cloitre (2010) tested a phased approach combining skills training in affect and interpersonal regulation with exposure against comparison conditions in adults with childhood abuse-related PTSD. The trial established an important experimental framework for evaluating sequencing, rather than leaving the question solely to clinical tradition.

The Schaug (2025) found low-certainty evidence concerning the incremental value of skills training for ICD-11 CPTSD and formulated a weak recommendation for trauma-focused psychotherapy with or without an added skills phase. This finding leaves room for flexible case formulation, while rejecting unwarranted certainty that all complex presentations require the same compulsory long preparatory sequence.

Research into complex PTSD requires consistent diagnostic instruments, carefully characterized comorbidity, clinically relevant outcomes beyond the core PTSD syndrome, and trials powered to test treatment interactions rather than only overall mean efficacy. The field's development increasingly treats complexity as an empirical moderator to investigate, not an automatic reason to exclude people from trauma-focused care.

Dissociation, Memory Discontinuity, and Treatment Adaptation

Dissociative symptoms may involve depersonalization, derealization, gaps in awareness, altered attention to the present, or marked changes in the felt ownership of memory and action. These experiences can affect informed consent, the tolerability of sustained memory-focused work, and the validity of symptom assessment. They also occur across diagnostic categories and cannot be reduced to one unitary mechanism.

The CAPS-5 framework includes specifications for the dissociative subtype of PTSD, as described in the U.S. Department of Veterans Affairs (n.d.). In treatment studies, dissociation may be measured at baseline as a potential moderator, during sessions as a process variable, or at follow-up as a secondary outcome. Each timing answers a different question. High dissociation before treatment is not equivalent to dissociative destabilization caused by a treatment protocol.

A Schaug (2025) found limited and very low-certainty comparative data for PTSD psychotherapies when dissociative symptoms co-occur. Its advice to attend clinically to dissociation should not be reinterpreted as proof that a single named stabilization method is necessary for all such patients. The present evidence supports careful assessment, collaborative adaptation, and better trials that explicitly measure these processes.

Mechanistic studies might distinguish memory accessibility, emotional numbing, attentional allocation, and the person's perception of present safety. These constructs are related yet require different instruments. If measured only through a broad dissociation score, apparent treatment moderation may reflect baseline PTSD severity or another comorbid condition rather than a specific dissociative mechanism.

An adequate trial would specify whether dissociation is an eligibility condition, a baseline predictor, a time-varying mediator, or an adverse outcome; register the planned interaction test; and include enough participants across relevant severity ranges. It would also describe how clinicians responded when symptoms interfered with treatment. These design decisions would transform the common clinical observation that dissociation matters into a more precise science of safe, effective adaptation.

PTSD With Personality Pathology and Self-Harm Risk

Repeated interpersonal trauma sometimes co-occurs with emotional instability, chronic self-injury, interpersonal disruption, or personality disorder. These complex presentations create a particularly demanding evidence question because intervention priorities include both trauma symptoms and behaviors that may endanger the patient's immediate safety. Researchers must avoid treating a diagnostic label as an invariant description of treatment capacity.

In a randomized comparison, Bohus (2020) examined dialectical behavior therapy adapted for PTSD (DBT-PTSD) against CPT among women with complex presentations related to childhood abuse. This study contributes evidence on specialist interventions that combine trauma work with skills targeting intense emotion and associated problems. Its population and setting remain important to interpretation of its relative effects.

The Schaug (2025) reported a conditional recommendation for DBT-PTSD in PTSD co-occurring with borderline personality disorder and noted potential benefits for related symptoms; its overall assessment of certainty was low. A treatment advantage for one domain does not mean that a comparator failed to improve the core PTSD syndrome, and a specialist trial does not justify universal treatment selection for every person with a history of childhood abuse.

Scientific monitoring in such populations needs repeated safety assessment, clear definitions of self-injurious behavior, recording of crises and service contacts, and outcomes that reflect interpersonal functioning and quality of life. Treatment discontinuation may arise from different causes than in less complex populations, including housing instability, access barriers, and competing psychiatric care. Missing follow-up should therefore be analyzed as part of the phenomenon rather than discarded as mere administrative noise.

The field should expand the involvement of people with complex presentations in research while protecting participants through competent clinical oversight. Greater inclusion demands better trial design and safety systems, rather than reducing diagnostic complexity to a reason for permanent research exclusion.

Military Trauma, Sexual Violence, Displacement, and Continuing Threat

Traumatic exposures differ in social meaning, recurrence, interpersonal context, and the extent to which danger has actually ended. Combat exposure, military sexual trauma, rape, torture, forced displacement, medical catastrophe, interpersonal violence, and repeated childhood maltreatment may produce overlapping PTSD symptoms while also generating distinctive problems of moral injury, institutional trust, physical injury, legal precarity, and social support.

Steenkamp (2015) critically reviewed psychotherapy trials in military-related PTSD, raising questions about treatment response and residual symptoms in veteran populations. The large randomized Schnurr (2022) comparison of PE with CPT provides more direct contemporary evidence in U.S. veterans, though its composition and service setting should not be mistaken for a globally representative trauma population.

Work among survivors of sexual violence contributed significantly to the foundational trials: Resick (2002) compared CPT with PE in women who had experienced rape, and Foa (2005) evaluated PE procedures in female assault survivors. Those studies are important precisely because their exposure type and participant selection are known. The findings cannot be extended without qualification to men, nonbinary patients, children, survivors of systemic persecution, or patients under continuing coercion.

Neuner (2004) studied narrative exposure in a refugee settlement. It demonstrated the feasibility of bringing randomized treatment research into a setting with substantial social adversity. However, a favorable treatment outcome does not mean that war, insecurity, marginalization, or material deprivation have become clinically irrelevant. Trauma-focused psychotherapy and social protection address different but connected dimensions of human recovery.

The research program should use culturally valid assessment, explicit description of exposure histories, and local expertise when translating interventions. Current danger requires a separate judgment from conditioned fear of past danger. Culturally sensitive treatment research must make room for accurate social appraisals while investigating avoidant or intrusive psychological processes that continue to impair functioning. A therapy's scientific evidence is strongest when the actual conditions of participants' lives are represented in both the research question and the outcome.

Delivery Through Telehealth and Digital Intervention

The delivery system is part of psychotherapy's real-world effectiveness. Live video sessions, supported online modules, blended care, telephone follow-up, and face-to-face sessions differ in privacy, therapeutic contact, technical reliability, accessibility, and the opportunity to respond to clinical distress. A digital treatment interface should therefore be evaluated as a specific method of service delivery rather than assumed equivalent to the therapy's in-person form.

The Schnurr (2024) supports secure video delivery of recommended psychotherapy when the approach has evidence for that format or where alternatives are unavailable. National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018) considers supported trauma-focused computerized CBT in a defined adult population and specifies trained practitioner guidance and symptom-related conditions. These recommendations show why the terms remote, computerized, guided, self-help, and teletherapy cannot be used as synonyms.

Research on telehealth effectiveness should test whether the same manualized protocol is delivered with comparable fidelity, whether participants have privacy for trauma-memory work, and what happens when a connection fails during an emotionally demanding part of a session. Equity matters because digital access, reliable hardware, language accessibility, and a private room are distributed unevenly across populations.

Outcome studies must distinguish clinical efficacy among users who complete an online program from the broader question of population effectiveness when many eligible patients lack access, decline enrollment, or disengage. An online treatment may increase geographic reach while simultaneously selecting for people with higher digital literacy or more stable living conditions. Equal mean outcomes in selected users do not prove equal access to effective care.

Artificial systems may eventually support appointment organization, structured outcome monitoring, accessibility, translation, and research-level identification of treatment patterns. Such systems introduce distinct requirements for confidentiality, consent, error handling, clinical accountability, and validation against human assessment. An automated conversational service should not be represented as delivering evidence-based PE, CPT, or EMDR merely because it can generate supportive language or describe a manual. The established clinical evidence belongs to professionally delivered, operationally defined interventions and must be re-established for materially altered delivery systems.

Clinical Alliance, Competence, and Treatment Fidelity

A treatment's manual supplies a set of procedures, whereas the clinical relationship shapes how those procedures are understood, undertaken, and sustained. Therapeutic alliance includes agreement about goals and tasks and a credible working bond. In PTSD research, alliance may affect engagement with difficult material, perceptions of safety, confidence in the treatment, and willingness to disclose symptom worsening or obstacles to attendance.

Interpreting alliance as the exclusive cause of improvement would exceed the evidence. In many studies, alliance is correlated with outcome after treatment begins; early symptom change may make alliance ratings more favorable, and shared patient characteristics can influence both. A compelling causal account requires repeated measurement, temporally sensitive analysis, and methods capable of distinguishing the direction of influence.

Protocol fidelity is another essential dimension. PE without adequately supported exposure, CPT without systematic examination of trauma-related cognitions, and EMDR without faithful adherence to its structured procedures may differ substantially from the interventions tested in efficacy trials. Fidelity ratings should ideally involve independent evaluation of session samples, with rater reliability and transparent thresholds. A protocol name alone is an insufficient description of what participants received.

Therapist competence, supervision, and service culture can determine whether standardized interventions are delivered safely and consistently. National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations (2018) explicitly emphasizes validated manuals, trained practitioners, and ongoing supervision for trauma-focused CBT. Implementation research should measure these elements along with patient outcomes, staff burden, equity, and maintenance of quality as programs scale.

Future trials can study the interaction of specific therapeutic components with alliance, responsiveness, and therapist competence, avoiding the assumption that method-specific and common factors compete for a fixed share of outcome. Treatment is an organized interpersonal process in which technique, clinical judgment, relationship, and institutional context interact over time.

Treatment Duration, Adherence, Dropout, and Follow-Up

PTSD psychotherapy outcomes depend on more than the mean symptom score among those who complete sessions. Treatment initiation, attendance, dosage, missed appointments, early termination, and posttreatment follow-up all affect the interpretation of both clinical efficacy and health-service value. A short intervention may improve overall accessibility, but the reasons for stopping are heterogeneous: symptom relief, insufficient benefit, transportation, cost, competing responsibilities, dissatisfaction, or adverse reactions.

The Sloan (2023) and the Sloan (2022) contribute to the question of clinical efficiency. Their noninferiority analyses and observed dropout patterns must be interpreted alongside the specific treatment schedules, margins, timing, and measured endpoints. Efficiency is a multidimensional property, not a synonym for a low session count.

Long-term follow-up asks whether early gains persist when memories are triggered by anniversaries, new stressors, bereavement, reinjury, or changing life circumstances. A clinically useful follow-up design distinguishes sustained remission, recurrence after improvement, delayed response, and initiation of new treatment. A cross-sectional snapshot six months after therapy cannot establish the detailed course of all four processes.

Attrition in randomized trials threatens both precision and validity. Missing data may be related to worsening symptoms or to unrelated practical obstacles, and these mechanisms have different implications. Analyses should describe missingness, imputation assumptions, sensitivity analyses, and the extent to which participants received their assigned treatment. It is especially important that researchers do not interpret the absence of recorded adverse events among people lost to follow-up as evidence of safety.

Future research should report patient-valued recovery, sustained functioning, engagement, and burden as core outcomes alongside standardized symptom severity. Such a design helps determine whether statistically detectable differences between therapies have practical importance for people navigating chronic trauma-related difficulties.

Cultural Adaptation, Equity, and the Limits of Generalization

The science of PTSD psychotherapy is international, yet much of its most influential randomized evidence has come from particular institutions, languages, and high-income service systems. Many trauma-exposed populations have limited access to specialist care or experience forms of violence not adequately reflected in the conventional clinical trial. An evidence base can be rigorous within its own samples while requiring targeted extension to other contexts.

Cultural adaptation entails more than translation. It may require revising examples, clarifying the meaning of symptoms and distress, adapting family involvement, acknowledging community and religious contexts, and examining whether local categories of suffering map onto the instrument's constructs. Adaptation must preserve enough of the treatment's active components to make a scientifically meaningful comparison while permitting culturally appropriate implementation.

The Neuner (2004) refugee-settlement trial offers one important model of context-sensitive experimental evaluation. The World Health Organization. (2024 (n.d.) further frames PTSD treatment as a global public-health concern. Neither source proves that one locally studied adaptation will produce the same effect in every displaced community or humanitarian emergency.

Equity-oriented trials should document language, socioeconomic conditions, forced displacement status where ethically appropriate, gender and age distribution, disability access, and whether participants face continuing danger. They should also investigate whether clinician training, remote infrastructure, and support for transport or childcare alter treatment uptake. These factors can influence effective access more strongly than modest differences between protocols.

An ethically sound research program includes community consultation, appropriate confidentiality safeguards, informed consent adapted to language and vulnerability, and transparent reporting of who was excluded. This combination preserves methodological discipline while expanding the scientific population to which psychotherapy knowledge can apply.

Comparative Efficacy and the Meaning of Treatment Rankings

The evidentiary conclusion that trauma-focused psychotherapy works for many adults with PTSD is supported by several layers of research. Efficacy trials demonstrate advantage over delayed treatment and some control conditions, head-to-head studies test differences between established procedures, and systematic reviews examine whether estimates remain credible across settings, intervention families, and populations. Each layer carries a distinctive claim, and an integrated judgment requires explicit attention to its denominator and comparator.

Hoppen (2023) identified 157 randomized controlled trials enrolling 11,565 patients in a network and pairwise meta-analysis. The intervention taxonomy included trauma-focused cognitive behavioral therapy, EMDR, other trauma-focused interventions, and non-trauma-focused therapies. All intervention classes improved symptoms relative to control conditions, whereas network comparisons did not establish statistically significant differences between the major classes. In pairwise synthesis, trauma-focused CBT showed a small advantage over non-trauma-focused approaches at short, intermediate, and longer-term assessment. For comparisons involving longer-term efficacy, the standardized difference was g = 0.20, with a reported 95% confidence interval from 0.04 to 0.35. This is evidence of an average advantage under heterogeneous study conditions rather than evidence of a universal treatment ranking.

That same synthesis observed slightly more discontinuation from trauma-focused CBT than from non-trauma-focused interventions: risk ratio 1.36, 95% confidence interval 1.08–1.70 in the relevant pairwise comparisons. The authors reported evidence of inconsistency and high outcome heterogeneity. Discontinuation is commonly used as a pragmatic proxy for acceptability, but it is a composite endpoint. Patients may leave for recovery, deterioration, scheduling barriers, or unrelated social reasons; a pooled all-cause rate cannot isolate any of these pathways. The finding should inform treatment-burden research rather than imply that trauma-focused procedures are intrinsically unsafe.

The early Schnurr (2007) trial provides an unusually clear active-comparator example. In 284 women veterans or active-duty service members randomized to prolonged exposure or present-centered therapy, PE produced a statistically greater mean reduction of PTSD symptoms. The reported between-treatment effect size was 0.27. The percentage no longer meeting PTSD criteria was 41.0% with PE versus 27.8% with PCT, whereas total remission was 15.2% versus 6.9%. These denominators and endpoints demonstrate both clinical benefit and the persistence of unmet needs after an effective treatment.

Direct comparison of PE and CPT in the large Schnurr (2022) contributes a different kind of information: differences between two established treatment options can be statistically distinguishable and clinically modest. This practical distinction underlies a patient-centered hierarchy in which access to competent delivery, informed preference, and capacity to complete the treatment may matter at least as much as small mean differences across protocols.

A meaningful evidence synthesis therefore compares trial quality, treatment duration, baseline severity, comparator intensity, follow-up, clinician-rated and self-rated outcomes, and loss of participants before drawing a conclusion about comparative efficacy. A large within-treatment effect cannot be equated with a large advantage over an active comparator. Equally, the absence of statistically significant differences in a sparse network does not establish true equivalence of every approach.

Proposed Mechanisms, Mediation, and Neurobiological Evidence

A scientifically adequate mechanism explains how a therapeutic intervention changes the processes that maintain distress, while specifying what observation might refute the account. For PE, central hypotheses include reduced avoidance, expectancy violation, and improved discrimination between reminders of past danger and actual present threat. For CPT, mechanisms include changes in trauma-related attributions, beliefs, and meanings. For cognitive therapy, alterations in trauma-memory context and threat appraisal are central. For EMDR, hypotheses include the effects of dual-attention memory processing and related cognitive load.

These mechanisms may overlap. Patients receiving PE often revise their beliefs about danger and responsibility; patients receiving CPT may become less avoidant of traumatic memory; EMDR involves sustained attention to clinically significant memories and meanings. An intervention-specific claim requires evidence that its distinctive component produces an effect after other plausible therapeutic ingredients have been controlled. Manual labels are therefore informative about therapeutic organization, but are not direct measurements of biological processes.

The foundational Foa (1986) formulation focused on fear structures and emotional processing, while Ehlers (2000) articulated a cognitive maintenance theory centered on current threat. These theories organize testable questions at the level of learning, memory, attention, interpretation, and behavior. Neither identifies a single biomarker through which all PTSD improvement must pass.

The Lee (2013) meta-analysis on eye movements contributes component-level evidence relevant to hypotheses about memory vividness and emotionality. Its interpretation should be limited to the tasks, populations, and designs included; a laboratory change in a traumatic or aversive memory is not identical to remission of PTSD. Similarly, neural imaging changes observed after treatment may represent compensatory adaptation, downstream symptom improvement, nonspecific learning, or measurement variability.

To establish mediation, studies must measure treatment delivery before mediator change and mediator change before outcome change, while addressing unmeasured confounding and reciprocal effects. Randomization of treatment does not randomize the mediator. Sequential randomization, component dismantling, multiple repeated observations, transparent causal models, and preregistered analyses would strengthen inferences. Biological correlates require reproducibility across scanners, tasks, statistical pipelines, and patient samples before being considered clinically actionable.

Mechanistic integration can therefore be organized across interacting levels: autobiographical memory access; threat-related meaning; anticipatory emotion; behavioral approach or avoidance; relational expectations; and functional choices in the environment. A treatment may modify several levels in parallel. The object of future research is to identify their time-ordered causal organization and whether specific intervention ingredients are especially efficient for particular profiles.

Recovery, Relapse, and Longitudinal Outcomes

The end of a prescribed treatment course is one point in the trajectory of recovery. Symptoms may continue to improve, stabilize, recur, or fluctuate as the person encounters new reminders or environmental stressors. Clinical trials that define success only at immediate posttreatment assessment obscure these differences and may overstate how much evidence exists for lasting functional restoration.

Longitudinal studies should distinguish symptom reduction, reliable response, diagnostic remission, restoration of participation, and relapse after remission. These are different outcomes and require prospectively specified measurement rules. Participants who do not complete follow-up may systematically differ from those who remain, and additional treatment obtained after the randomized trial may contribute to apparent durability.

A person may recover the capacity to work, parent, study, or maintain relationships while some intrusive memories remain. Another may no longer meet a diagnostic threshold yet experience continuing pain, insomnia, or social restriction. Measurement systems centered solely on a total PTSD score can miss these meaningful distinctions. Research should therefore include patient-reported functioning, quality of life, safety, employment or education participation, and social relationships while avoiding the assumption that one cultural model of recovery applies universally.

Hoppen (2023) examined longer-term efficacy across trials, but the smaller set of long-term comparisons and substantial heterogeneity limit claims about individual durability. Longitudinal comparative studies with harmonized follow-up intervals are needed to test whether initial treatment differences persist beyond the active phase. The observation that a therapy produces faster symptom reduction must also be separated from the possibility that slower-responding participants eventually reach similar outcomes.

The major unresolved question is how to identify early signs of insufficient response without prematurely switching an intervention that remains effective for the person. Repeated measurement and collaborative clinical review can support adaptive treatment, but clinical decision thresholds should be tested rather than assumed. Sequential randomized trials and adaptive designs offer promising methods for establishing when to continue, augment, switch, or step down care.

Implementation, Training, and Health-System Translation

The availability of a scientifically supported psychotherapy does not guarantee that the intervention reaches those who might benefit. Health systems face constraints involving workforce training, referral pathways, reimbursement, privacy, geographic access, language, cultural fit, and the practical burden of weekly appointments. The translation from efficacy to equitable effectiveness thus requires its own body of research.

Manualized treatment is a set of clinical competencies as well as a written text. Establishing a training program entails supervision, feedback on case formulation, fidelity assessment, response to complex comorbidity, and the maintenance of competence over time. Routine clinical services may deliver a therapy with adapted schedules, variable caseloads, and different specialist resources from the original efficacy setting. Outcomes in these services should be measured instead of inferred from the intervention name.

An implementation study can examine the proportions of eligible patients who are offered treatment, initiate it, receive a meaningful dosage, complete or appropriately transition from care, and achieve a prespecified benefit. Such a funnel highlights structural loss before therapy begins. It also avoids attributing low population recovery to the psychotherapy itself when the main cause is limited availability or unequal access.

The development of brief treatments such as Sloan (2023) creates a testable opportunity to improve throughput and patient convenience. Yet treatment efficiency should measure patient time, clinician time, training intensity, recovery, adverse events, and continuity of care together. A cheaper intervention that yields lower access barriers may provide major public benefit; the relevant trade-off is empirical and depends on the service population.

Global translation adds language and resource demands. Community-delivered TF-CBT trials and refugee-setting NET trials illustrate approaches to extending the evidence beyond specialist clinics. Ongoing evaluation must attend to privacy, continuing danger, protection of children, treatment fidelity, and the extent to which symptom instruments capture outcomes meaningful to participants. Effective implementation is a sustained institutional achievement, not an automatic consequence of publishing a guideline.

Risk of Bias, Replication, and Evidence Boundaries

Random allocation reduces some sources of confounding, but psychotherapy research retains characteristic methodological vulnerabilities. Participants and therapists usually know their assignment; therapist allegiance can affect both delivery and perceived credibility; trial protocols vary in fidelity; and outcome assessors may inadvertently acquire knowledge of allocation. A high-quality study therefore reports prespecified outcomes, masking where feasible, randomization integrity, treatment adherence, sample flow, missing-data handling, and deviations from the original analysis plan.

Small samples generate imprecise estimates and are particularly vulnerable to extreme effects. Small-study effects, selective publication, and the difficulty of obtaining neutral or negative trials can distort pooled outcomes. A systematic review may produce a narrow pooled interval while still representing an underlying literature whose studies are heterogeneous or biased. Independent replication by teams not responsible for developing the intervention is especially important.

The Hoppen (2023) network meta-analysis explicitly reported high outcome heterogeneity and some inconsistency. These limitations matter when interpreting its indirect comparisons. Intervention packages were heterogeneous, and trial settings differed substantially. Network estimates should accordingly be used to understand general patterns and identify evidence gaps rather than as a precision ranking for every patient.

The Schaug (2025) guideline synthesis for complex PTSD presentations found several clinically relevant effects but rated parts of the evidence as low or very low certainty. This illustrates a broader fact: evidence for a common PTSD treatment can be substantial while its effects in a precisely defined comorbid subgroup are less certain. Scope-specific certainty is an essential component of responsible scientific interpretation.

A rigorous research program should register clinical trial protocols, identify primary estimands and minimal clinically important differences, make deidentified data and reproducible analysis code available where ethically and legally feasible, publish adverse-event definitions, and maintain transparent records of changes to procedures. Individual-participant-data meta-analysis could further test moderators that aggregate analyses are underpowered to identify. The aim is a research corpus in which scientific confidence can be audited and updated as new studies arrive.

Artificial Era, Digital Systems, and Psychological Treatment Science

The Artificial Era introduces new instruments for the study, organization, and possible support of psychological care. Machine learning can be used to analyze time-varying symptom data, explore heterogeneity of treatment response, identify missingness patterns, and evaluate scheduling or resource allocation. Natural-language systems can assist with structured educational materials, research synthesis, accessible explanations, and administrative workflows under appropriate oversight.

These technological capabilities do not themselves establish clinical efficacy for a psychological intervention. A language model may reproduce the vocabulary of CPT, PE, or EMDR without reliably maintaining the clinical structure, informed consent, risk assessment, and crisis response required in a validated therapeutic encounter. Evidence for a human-delivered, manualized treatment cannot simply be transferred to an autonomous digital implementation. A new delivery system is a new intervention requiring prospective evaluation.

A scientifically productive program begins with operational definitions. Artificial cognition refers to information-processing capabilities of designed systems; artificial agency describes measurable capacities for goal-directed selection and action under specified constraints; and artificial memory refers to persistence and retrieval of representational states within a designed architecture. Their relationship to psychotherapy outcomes is an empirical research question, addressed through defined interfaces and actual patient outcomes rather than analogy alone.

Research involving automated clinical support should test prediction calibration, subgroup fairness, privacy, cybersecurity, data governance, response to emergencies, clinician oversight, and the consequences of errors. Prospective randomized or otherwise credible comparative evaluations should measure patient-valued outcomes, harm, consent, and service accessibility. Training data derived from therapeutic conversations introduce additional ethical challenges because these records are exceptionally sensitive and may include identifying information about third parties.

The Artificial Era therefore expands the research infrastructure through which PTSD treatment can be studied, monitored, and made accessible, while introducing new causal, legal, and ethical questions. A central distinction remains necessary between evidence that a technological system can describe a therapy, evidence that it can assist clinicians, and evidence that a specific system improves patient outcomes. Each demands a different validation study.

Critical Scientific Discussion

The accumulated literature supports a broad conclusion: well-defined, trauma-focused psychological interventions can materially reduce PTSD symptoms, and PE, CPT, and EMDR have substantial support in adult clinical guidance. Trauma-focused cognitive and exposure procedures, narrative approaches, brief written protocols, developmental TF-CBT, and specialized treatments for complex presentations are parts of a differentiated scientific landscape. The strength of evidence varies across protocols, populations, outcomes, and time horizons.

The first major dispute concerns comparative superiority. Trials using waitlist conditions can report large benefits but cannot answer whether one active psychotherapy is better than another. Active-comparator and network evidence generally reveals smaller differences and greater uncertainty. The practical significance of a difference depends on its magnitude, clinical threshold, patient preferences, implementation cost, and durability. The central research objective should be reliable benefit for defined patients rather than an unconditional ranking of branded protocols.

The second dispute concerns explanatory mechanisms. Many treatments overlap in exposure to traumatic memory, cognitive updating, relational support, reduced avoidance, and restoration of agency. Distinctive components such as eye movements, written exposure, structured belief examination, or autobiographical narration warrant direct experimental analysis. The literature has advanced further in establishing the efficacy of several packages than in proving precisely which ingredient produces every observed clinical effect.

The third dispute concerns complexity and treatment sequencing. Trials with high-comorbidity patients and the 2025 clinical guideline provide evidence that trauma-focused treatment can be beneficial in complex presentations. At the same time, the certainty of differential treatment recommendations for narrowly defined comorbid subgroups remains limited. Research should replace blanket exclusions or compulsory assumptions about treatment phases with careful assessment and trials that explicitly test moderators and sequencing strategies.

The fourth dispute concerns the translation from specialist trials to diverse populations. Access, cultural context, ongoing threat, youth development, disability, clinician training, and health-system resources all influence who receives effective care and what improvement means. A treatment science focused only on laboratory or specialist-clinic averages would leave this central public-health question unanswered. Pragmatic trials, culturally grounded adaptation, and implementation research must therefore be treated as components of fundamental evidence.

The fifth dispute concerns safety and the incompleteness of published outcome records. Symptom change, discontinuation, exposure-related distress, sustained deterioration, and adverse events require separate measurement. Strong treatment recommendations are fully compatible with the need for better adverse-outcome reporting and qualified clinical judgment. A careful safety framework improves scientific knowledge and protects the quality of treatment translation.

The direction of a mature research program is consequently integrative: precise diagnosis, multiple measurement perspectives, robust active comparisons, repeated mechanism testing, inclusive samples, clinically meaningful recovery outcomes, qualified practitioners, and transparent reproducible methods. The resulting knowledge should support both scientific explanation and safe treatment availability.

Conclusion

Psychological treatments for trauma and PTSD constitute a major field of empirically tested clinical intervention. Its foundational achievement is the demonstration that persistent trauma-related symptoms can change through structured psychological procedures, with particularly substantial evidence supporting trauma-focused treatments. Prolonged exposure, cognitive processing therapy, and EMDR occupy prominent places in contemporary adult PTSD guidance; additional protocols extend the research into brief treatment, narrative integration, childhood trauma, comorbidity, and complex presentations.

The core scientific task is now to explain heterogeneity. Patients differ in trauma histories, clinical symptom structures, social environments, developmental stages, preferences, and capacity to access care. Treatments differ in procedures, time demands, theoretical emphases, and delivery systems. High-quality research must connect these variations with reliable measures of change and with outcomes extending beyond symptom checklists to safety, participation, and sustained recovery.

A second major task is mechanistic precision. Therapeutic efficacy and the causal pathways producing it are separate research achievements. Advances require component experiments, temporally ordered mediation studies, direct active-treatment comparisons, independent replication, and reliable long-term follow-up. The continued development of clinical science depends on retaining this distinction while integrating knowledge across memory, appraisal, emotion, behavior, relationships, and institutions.

Finally, equitable dissemination is part of the scientific object. The effects of a protocol are realized through trained clinicians, accessible services, culturally meaningful communication, and conditions of personal safety. Emerging artificial systems may extend research and support infrastructure when their actual benefits and risks are established by rigorous evaluation. The durable conclusion is that evidence-based psychological care for PTSD is a differentiated, expanding body of knowledge whose effectiveness, mechanisms, safety, and social reach must be examined together.

References

  • American Psychological Association. (2025). Clinical practice guideline for the treatment of posttraumatic stress disorder (PTSD) in adults. American Psychological Association. https://www.apa.org/ptsd-guideline
  • Bohus, M., Kleindienst, N., Hahn, C., Müller-Engelmann, M., Ludäscher, P., Steil, R., Fydrich, T., Kuehner, C., Resick, P. A., Stiglmayr, C., Schmahl, C., & Priebe, K. (2020). Dialectical behavior therapy for posttraumatic stress disorder (DBT-PTSD) compared with cognitive processing therapy (CPT) in complex presentations of PTSD in women survivors of childhood abuse: A randomized clinical trial. JAMA Psychiatry, 77(12), 1235–1245. https://doi.org/10.1001/jamapsychiatry.2020.2148
  • Bovin, M. J., Marx, B. P., Weathers, F. W., Gallagher, M. W., Rodriguez, P., Schnurr, P. P., & Keane, T. M. (2016). Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders—Fifth Edition (PCL-5) in veterans. Psychological Assessment, 28(11), 1379–1391. https://doi.org/10.1037/pas0000254
  • Bryant, R. A., Mastrodomenico, J., Felmingham, K. L., Hopwood, S., Kenny, L., Kandris, E., Cahill, C., & Creamer, M. (2008). Treatment of acute stress disorder: A randomized controlled trial. Archives of General Psychiatry, 65(6), 659–667. https://doi.org/10.1001/archpsyc.65.6.659
  • Cloitre, M., Stovall-McClough, K. C., Nooner, K., Zorbas, P., Cherry, S., Jackson, C. L., Gan, W., & Petkova, E. (2010). Treatment for PTSD related to childhood abuse: A randomized controlled trial. American Journal of Psychiatry, 167(8), 915–924. https://doi.org/10.1176/appi.ajp.2010.09081247
  • Cohen, J. A., Deblinger, E., Mannarino, A. P., & Steer, R. A. (2004). A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms. Journal of the American Academy of Child & Adolescent Psychiatry, 43(4), 393–402. https://doi.org/10.1097/00004583-200404000-00005
  • Cohen, J. A., Mannarino, A. P., & Iyengar, S. (2011). Community treatment of posttraumatic stress disorder for children exposed to intimate partner violence: A randomized controlled trial. Archives of Pediatrics & Adolescent Medicine, 165(1), 16–21. https://doi.org/10.1001/archpediatrics.2010.247
  • Eberle, D. J., & Kontogeorgou, T.-Z. (2026). Clinical practice guidelines for the treatment of PTSD: A review and meta-guideline. European Journal of Trauma & Dissociation, 10(1), Article 100650. https://doi.org/10.1016/j.ejtd.2026.100650
  • Ehlers, A., & Clark, D. M. (2000). A cognitive model of posttraumatic stress disorder. Behaviour Research and Therapy, 38(4), 319–345. https://doi.org/10.1016/S0005-7967(99)00123-0
  • Ehlers, A., Clark, D. M., Hackmann, A., McManus, F., & Fennell, M. (2005). Cognitive therapy for post-traumatic stress disorder: Development and evaluation. Behaviour Research and Therapy, 43(4), 413–431. https://doi.org/10.1016/j.brat.2004.03.006
  • Foa, E. B., Hembree, E. A., Cahill, S. P., Rauch, S. A. M., Riggs, D. S., Feeny, N. C., & Yadin, E. (2005). Randomized trial of prolonged exposure for posttraumatic stress disorder with and without cognitive restructuring: Outcome at academic and community clinics. Journal of Consulting and Clinical Psychology, 73(5), 953–964. https://doi.org/10.1037/0022-006X.73.5.953
  • Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99(1), 20–35. https://doi.org/10.1037/0033-2909.99.1.20
  • Hoppen, T. H., Jehn, M., Holling, H., Mutz, J., Kip, A., & Morina, N. (2023). The efficacy and acceptability of psychological interventions for adult PTSD: A network and pairwise meta-analysis of randomized controlled trials. Journal of Consulting and Clinical Psychology, 91(8), 445–461. https://doi.org/10.1037/ccp0000809
  • Karatzias, T., Murphy, P., Cloitre, M., Bisson, J., Roberts, N., Shevlin, M., Hyland, P., Maercker, A., Ben-Ezra, M., Coventry, P., Mason-Roberts, S., Bradley, A., & Hutton, P. (2019). Psychological interventions for ICD-11 complex PTSD symptoms: Systematic review and meta-analysis. Psychological Medicine, 49(11), 1761–1775. https://doi.org/10.1017/S0033291719000436
  • Lee, C. W., & Cuijpers, P. (2013). A meta-analysis of the contribution of eye movements in processing emotional memories. Journal of Behavior Therapy and Experimental Psychiatry, 44(2), 231–239. https://doi.org/10.1016/j.jbtep.2012.11.001
  • National Institute for Health and Care Excellence. (2018). Post-traumatic stress disorder (NICE guideline NG116). https://www.nice.org.uk/guidance/ng116/chapter/recommendations
  • Neuner, F., Schauer, M., Klaschik, C., Karunakara, U., & Elbert, T. (2004). A comparison of narrative exposure therapy, supportive counseling, and psychoeducation for treating posttraumatic stress disorder in an African refugee settlement. Journal of Consulting and Clinical Psychology, 72(4), 579–587. https://doi.org/10.1037/0022-006X.72.4.579
  • Resick, P. A., Nishith, P., Weaver, T. L., Astin, M. C., & Feuer, C. A. (2002). A comparison of cognitive-processing therapy with prolonged exposure and a waiting condition for the treatment of chronic posttraumatic stress disorder in female rape victims. Journal of Consulting and Clinical Psychology, 70(4), 867–879. https://doi.org/10.1037/0022-006X.70.4.867
  • Rose, S., Bisson, J., Churchill, R., & Wessely, S. (2002). Psychological debriefing for preventing post traumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews, 2002(2), Article CD000560. https://doi.org/10.1002/14651858.CD000560
  • Schaug, J. P., Møller, L., Reinholt, N., Illum, D. B., Græbe, F. L., Mikkelsen, L. B., Austin, S. F., Paulsen, N. N., Porsing, A. M. T., Juul, S., Hovmand, O. R., Jørgensen, M. S., Arendt, I.-M. T. P., Quistgaard, M., Kristensen, M. T., Døssing, S. C. B., Rosenbaum, B., Rosenberg, N. G., Arnfred, S. M., & Storebø, O. J. (2025). Psychotherapies for adults with complex presentations of PTSD: A clinical guideline and five systematic reviews with meta-analyses. BMJ Mental Health, 28(1), Article e301158. https://doi.org/10.1136/bmjment-2024-301158
  • Schnurr, P. P., Chard, K. M., Ruzek, J. I., Chow, B. K., Resick, P. A., Foa, E. B., Marx, B. P., Friedman, M. J., Bovin, M. J., Caudle, K. L., Castillo, D., Curry, K. T., Hollifield, M., Huang, G. D., Chee, C. L., Astin, M. C., Dickstein, B., Renner, K., Clancy, C. P.,. Shih, M.-C. (2022). Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US veterans: A randomized clinical trial. JAMA Network Open, 5(1), Article e2136921. https://doi.org/10.1001/jamanetworkopen.2021.36921
  • Schnurr, P. P., Friedman, M. J., Engel, C. C., Foa, E. B., Shea, M. T., Chow, B. K., Resick, P. A., Thurston, V., Orsillo, S. M., Haug, R., Turner, C., & Bernardy, N. (2007). Cognitive behavioral therapy for posttraumatic stress disorder in women: A randomized controlled trial. JAMA, 297(8), 820–830. https://doi.org/10.1001/jama.297.8.820
  • Schnurr, P. P., Hamblen, J. L., Wolf, J., Coller, R., Collie, C., Fuller, M. A., Holtzheimer, P. E., Kelly, U., Lang, A. J., McGraw, K., Morganstein, J. C., Norman, S. B., Papke, K., Petrakis, I., Riggs, D., Sall, J. A., Shiner, B., Wiechers, I., & Kelber, M. S. (2024). The management of posttraumatic stress disorder and acute stress disorder: Synopsis of the 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense clinical practice guideline. Annals of Internal Medicine, 177(3), 363–374. https://doi.org/10.7326/M23-2757
  • Shapiro, F. (1989). Efficacy of the eye movement desensitization procedure in the treatment of traumatic memories. Journal of Traumatic Stress, 2(2), 199–223. https://doi.org/10.1002/jts.2490020207
  • Sloan, D. M., Marx, B. P., Acierno, R., Messina, M., Muzzy, W., Gallagher, M. W., Litwack, S., & Sloan, C. (2023). Written exposure therapy vs prolonged exposure therapy in the treatment of posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 80(11), 1093–1100. https://doi.org/10.1001/jamapsychiatry.2023.2810
  • Sloan, D. M., Marx, B. P., Lee, D. J., & Resick, P. A. (2018). A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: A randomized noninferiority clinical trial. JAMA Psychiatry, 75(3), 233–239. https://doi.org/10.1001/jamapsychiatry.2017.4249
  • Sloan, D. M., Marx, B. P., Resick, P. A., Young-McCaughan, S., Dondanville, K. A., Straud, C. L., Mintz, J., Litz, B. T., & Peterson, A. L. (2022). Effect of written exposure therapy vs cognitive processing therapy on increasing treatment efficiency among military service members with posttraumatic stress disorder: A randomized noninferiority trial. JAMA Network Open, 5(1), Article e2140911. https://doi.org/10.1001/jamanetworkopen.2021.40911
  • Steenkamp, M. M., Litz, B. T., Hoge, C. W., & Marmar, C. R. (2015). Psychotherapy for military-related PTSD: A review of randomized clinical trials. JAMA, 314(5), 489–500. https://doi.org/10.1001/jama.2015.8370
  • U.S. Department of Veterans Affairs, National Center for PTSD. (n.d.). Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). https://www.ptsd.va.gov/professional/assessment/adult-int/caps.asp
  • U.S. Department of Veterans Affairs & U.S. Department of Defense. (2023). VA/DoD clinical practice guideline for management of posttraumatic stress disorder and acute stress disorder. https://www.healthquality.va.gov/guidelines/mh/ptsd/
  • Weathers, F. W., Bovin, M. J., Lee, D. J., Sloan, D. M., Schnurr, P. P., Kaloupek, D. G., Keane, T. M., & Marx, B. P. (2018). The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychological Assessment, 30(3), 383–395. https://doi.org/10.1037/pas0000486
  • World Health Organization. (2023). Post-traumatic stress disorder (PTSD): Psychological interventions, children and adolescents. WHO Mental Health Gap Action Programme evidence center. https://www.who.int/teams/mental-health-and-substance-use/treatment-care/mental-health-gap-action-programme/evidence-centre/conditions-related-to-stress/posttraumatic-stress-disorder-%28ptsd%29--psychological-interventions---children-and-adolescents
  • World Health Organization. (2024, May 27). Post-traumatic stress disorder. https://www.who.int/news-room/fact-sheets/detail/post-traumatic-stress-disorder